The Complexity of Malignant Glioma Treatment
Cancers · 04.03.2025 · 17 (5) · 879
DOI: 10.3390/cancers17050879 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 04.03.2025. Verfasst von Linde F C Kampers und 10 weiteren Autor:innen. Beteiligte Einrichtung: Immun-Onkologisches Zentrum Köln, 50674 Köln, Germany. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Malignant glioma is a highly aggressive, therapeutically non-responsive, and deadly disease with a unique tumor microenvironment (TME). Of the 14 currently recognized and described cancer hallmarks, five are especially implicated in malignant glioma and targetable with repurposed drugs: cancer stem-like cells, in general, and glioma stem-like cells in particular (GSCs), vascularization and hypoxia, metabolic reprogramming, tumor-promoting inflammation and sustained proliferative signaling. Each hallmark drives malignant glioma development, both individually and through interactions with other hallmarks, in which the TME plays a critical role. To combat the aggressive malignant glioma spatio-temporal heterogeneity driven by TME interactions, and to overcome its therapeutic challenges, a combined treatment strategy including anticancer therapies, repurposed drugs and multimodal immunotherapy should be the aim for future treatment approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Immun-Onkologisches Zentrum Köln, 50674 Köln, Germany.
- Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
- Hopp Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.
- German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
- German Consortium (DKTK), 69120 Heidelberg, Germany.
- Bambino Gesu' Children's Hospital-IRCCS, 00165 Rome, RM, Italy.
ORCID-Profile: Linde F C Kampers, Dennis S Metselaar, Maria Vinci, Fabio Scirocchi, Sophie Veldhuijzen van Zanten, Matthias Eyrich, Veronica Biassoni, Esther Hulleman, Michael Karremann, Stefaan W Van Gool
Zitieren
APA
Kampers, L. F. C., Metselaar, D. S., Vinci, M., Scirocchi, F., Veldhuijzen van Zanten, S., Eyrich, M., Biassoni, V., Hulleman, E., Karremann, M., Stücker, W., & Van Gool, S. W. (2025). The Complexity of Malignant Glioma Treatment. Cancers, 17(5), 879. https://doi.org/10.3390/cancers17050879
Vancouver
Kampers LFC, Metselaar DS, Vinci M, Scirocchi F, Veldhuijzen van Zanten S, Eyrich M, et al. The Complexity of Malignant Glioma Treatment. Cancers. 2025;17(5):879. doi:10.3390/cancers17050879
BibTeX
@article{Kampers2025,
author = {Kampers, Linde F C and Metselaar, Dennis S and Vinci, Maria and Scirocchi, Fabio and Veldhuijzen van Zanten, Sophie and Eyrich, Matthias and Biassoni, Veronica and Hulleman, Esther and Karremann, Michael and Stücker, Wilfried and Van Gool, Stefaan W},
title = {The Complexity of Malignant Glioma Treatment},
journal = {Cancers},
year = {2025},
volume = {17},
number = {5},
pages = {879},
doi = {10.3390/cancers17050879}
}
EUVIMED